Recent Advances in the Treatment of Preterm Newborn Infants with Patent Ductus Arteriosus
Copyright © 2016 Elsevier Inc. All rights reserved..
A patent ductus arteriosus (PDA) is associated with several adverse clinical conditions. Several strategies for PDA treatment exist, although data regarding the benefits of PDA treatment on outcomes are sparse. Moreover, the optimal treatment strategy for preterm neonates with PDA remains subject to debate. It is still unknown whether and when PDA treatment should be initiated and which approach (conservative, pharmacologic, or surgical) is best for individual patients (tailored therapies). This article reviews the current strategies for PDA treatment with a special focus on recent developments such as oral ibuprofen, high-dose regimens, and the use of paracetamol (oral, intravenous).
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2016 |
|---|---|
| Erschienen: |
2016 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:43 |
|---|---|
| Enthalten in: |
Clinics in perinatology - 43(2016), 1 vom: 15. März, Seite 113-29 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Sallmon, Hannes [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 13.12.2016 Date Revised 16.03.2022 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.clp.2015.11.008 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM257468706 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM257468706 | ||
| 003 | DE-627 | ||
| 005 | 20231224182910.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.clp.2015.11.008 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0858.xml |
| 035 | |a (DE-627)NLM257468706 | ||
| 035 | |a (NLM)26876125 | ||
| 035 | |a (PII)S0095-5108(15)00129-3 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Sallmon, Hannes |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Recent Advances in the Treatment of Preterm Newborn Infants with Patent Ductus Arteriosus |
| 264 | 1 | |c 2016 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 13.12.2016 | ||
| 500 | |a Date Revised 16.03.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2016 Elsevier Inc. All rights reserved. | ||
| 520 | |a A patent ductus arteriosus (PDA) is associated with several adverse clinical conditions. Several strategies for PDA treatment exist, although data regarding the benefits of PDA treatment on outcomes are sparse. Moreover, the optimal treatment strategy for preterm neonates with PDA remains subject to debate. It is still unknown whether and when PDA treatment should be initiated and which approach (conservative, pharmacologic, or surgical) is best for individual patients (tailored therapies). This article reviews the current strategies for PDA treatment with a special focus on recent developments such as oral ibuprofen, high-dose regimens, and the use of paracetamol (oral, intravenous) | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Ibuprofen | |
| 650 | 4 | |a Indomethacin | |
| 650 | 4 | |a Paracetamol | |
| 650 | 4 | |a Patent ductus arteriosus | |
| 650 | 4 | |a Preterm infant | |
| 650 | 4 | |a Very low birth weight | |
| 650 | 7 | |a Anti-Inflammatory Agents, Non-Steroidal |2 NLM | |
| 650 | 7 | |a Acetaminophen |2 NLM | |
| 650 | 7 | |a 362O9ITL9D |2 NLM | |
| 650 | 7 | |a Ibuprofen |2 NLM | |
| 650 | 7 | |a WK2XYI10QM |2 NLM | |
| 650 | 7 | |a Indomethacin |2 NLM | |
| 650 | 7 | |a XXE1CET956 |2 NLM | |
| 700 | 1 | |a Koehne, Petra |e verfasserin |4 aut | |
| 700 | 1 | |a Hansmann, Georg |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinics in perinatology |d 1983 |g 43(2016), 1 vom: 15. März, Seite 113-29 |w (DE-627)NLM000089141 |x 1557-9840 |7 nnns |
| 773 | 1 | 8 | |g volume:43 |g year:2016 |g number:1 |g day:15 |g month:03 |g pages:113-29 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.clp.2015.11.008 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 43 |j 2016 |e 1 |b 15 |c 03 |h 113-29 | ||